Herbert Virgin, EVP, Research & CSO at Vir Biotechnology, Inc. (VIR), sold 4,586 shares at $31.93 ($146K) on 2022-02-17, disclosed to the SEC on 2022-02-22.
Open-market sale of $146k VIR by EVP, Research & CSO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.93 | 2,293 | $73K | 50.0% |
| 2 | $31.93 | 2,293 | $73K | 50.0% |
| Total | $31.93 avg | 4,586 | $146K | 100% |
| Filing → |
| VIR | SELL | 2022-01-26 | $45K | — | Filing → |
| VIR | SELL | 2022-01-13 | $48K | — | Filing → |
| VIR | SELL | 2021-12-30 | $110K | — | Filing → |